NVE Corporation (NVEC)
After hours:
| Previous close | 84.22 |
| Open | 84.57 |
| Bid | 83.33 x 100 |
| Ask | 86.35 x 100 |
| Day's range | 83.73 - 85.26 |
| 52-week range | 64.14 - 90.24 |
| Volume | |
| Avg. volume | 22,220 |
| Market cap | 411.394M |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 24.46 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.00 (4.73%) |
| Ex-dividend date | 29 July 2024 |
| 1y target est | N/A |
- GlobeNewswire
NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend
EDEN PRAIRIE, Minn., July 17, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter ended June 30, 2024. Total revenue for the first quarter of fiscal 2025 decreased 23% to $6.78 million from $8.83 million for the prior-year quarter. The decrease was due to a 24% decrease in product sales partially offset by a 28% increase in contract research and development revenue. Net income for the first quarter of fiscal 2025 decreased 7% to $4.10 million
- GlobeNewswire
NVE Schedules Conference Call on First-Quarter Results
EDEN PRAIRIE, Minn., July 10, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended June 30, 2024 on Wednesday, July 17, 2024 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time. The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE’s Website (www.nve.com). An archive of the call wil
- GlobeNewswire
Dr. Kelly Wei Joins NVE Corporation’s Board of Directors
EDEN PRAIRIE, Minn., May 13, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today that its Board of Directors elected Kelly Wei, Ph.D. to join the Board, effective today, filling the unexpired term of Richard W. Kramp, who passed away recently. Dr. Wei will also serve on the Board’s Compensation Committee and Nominating and Corporate Governance Committee. Mr. Kramp’s unexpired term ends at NVE’s 2024 annual shareholders’ meeting. The Board expects to nominate Dr. Wei for a ful
